The novel-response procedure in humans

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 2, 1999, Pages 245-250

  Smith, Brandi J ^a   Bickel, Warren K ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Benzodiazepines; Drug discrimination; Humans; Novel response procedure; Triazolam

Indexed keywords

ALPRAZOLAM; AMPHETAMINE; BUSPIRONE; CAFFEINE; DIAZEPAM; HYDROMORPHONE; LORAZEPAM; PLACEBO; SECOBARBITAL; TRIAZOLAM; ZOLPIDEM;

CLINICAL TRIAL; CONFERENCE PAPER; CROSSOVER PROCEDURE; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; HUMAN; HUMAN EXPERIMENT; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; REINFORCEMENT; TRAINING; VOLUNTEER;

ANTI-ANXIETY AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DISCRIMINATION (PSYCHOLOGY); HUMANS; HYPNOTICS AND SEDATIVES; NARCOTICS; REINFORCEMENT SCHEDULE; TRIAZOLAM;

EID: 0032840701     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00061-1     Document Type: Conference Paper

References (25)

1. Ator N.A., Griffiths R.R. Lorazepam and pentobarbital drug discrimination in baboons. Cross-generalization and interaction with RO-15-1788 J. Pharmacol. Exp. Ther. 226:1983;776-782.
2. Ator N.A., Griffiths R.R. Discriminative stimulus effects of atypical anxiolytics in baboons and rats. J. Pharmacol. Exp. Ther. 237:1986;393-403.
3. Ator N.A., Griffiths R.R. Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam. Psychopharmacology (Berlin). 98:1989;20-30.
4. Ator N.A., Griffiths R.R. Selectivity in the generalization profile in baboons trained to discriminate lorazepam. Benzodiazepines, barbiturates and other sedative/anxiolytics J. Pharmacol. Exp.Ther. 282:1997;1442-1457.
5. Bickel W.K., Oliveto A.H., Kamien J.B., Higgins S.T., Hughes J.R. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. J. Pharmacol. Exp. Ther. 264:1993;360-367.
6. Bickel W.K., Bigelow G.E., Preston K.L., Liebson I.A. Opioid drug discrimination in humans. Stability, specificity and relation to self-reported drug effect J. Pharmacol. Exp. Ther. 251:1989;1053-1063.
7. Frey J.M., Mintzer M.Z., Rush C.R., Griffiths R.R. Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure. Psychopharmacology (Berlin). 138:1998;16-26.
8. Garcha H.S., Rose I.C., Stolerman I.P. Midazolam as a cue in rats. Generalization tests with anxiolytics and other drugs Psychopharmacology (Berlin). 87:1985;233-237.
9. Hendry J.S., Balster R.L., Rosencrans J.A. Discriminative stimulus properties of buspirone compared to central nervous system depressants in rats. Pharmacol. Biochem. Behav. 19:1983;97-101.
10. Jasinski D.R. Assessment of the abuse potential of morphine-like drugs (methods used in man). Martin W.R. Drug addiction I. 1977;197-258 Springer, New York.
11. Johanson C.E. Further studies on the discriminative stimulus effects of diazepam in humans. Behav. Pharmacol. 2:1991;357-367.
12. Kamien J.B., Bickel W.K., Oliveto A.H., Smith B.J., Higgins S.T., Hughes J.R. Triazolam discrimination by humans under a novel response procedure. Effects of buspirone and lorazepam Behav. Pharmacol. 5:1994;315-325.
13. Kamien J.B., Bickel W.K., Smith B.J., Badger G.B., Hughes J.R. Secobarbital in humans discriminating triazolam under two-response and novel-response procedures. Pharmacol. Biochem. Behav. 58:1997;983-991.
14. Martin W.R., Sloan J.W., Sapiro J.D., Jasinski D.R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin. Pharmacol. Ther. 12:1971;245-258.
15. McLeod D.R., Griffiths R.R., Bigelow G.E., Yingling J. An automated version of the digit symbol substitution test (DSST). Behav. Res. Methods Instrum. 14:1982;436-466.
16. Mintzer, M. Z.; Frey, J. M.; Griffiths, R. R.: Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure. Behavioral Pharmacology 1998 9:545-559.
17. Nierenberg J., Ator N.A. Drug discrimination in rats successfully trained to discriminate diazepam and pentobarbital. Pharmacol. Biochem. Behav. 35:1990;405-412.
18. Oliveto A.H., Bickel W.K., Kamien J.B., Hughes J.R., Higgins S.T. Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology (Berlin). 114:1994;417-423.
19. Overton D.A. Historical context of state-dependent learning and discriminative drug effects. Behav. Pharmacol. 2:1991;253-264.
20. Preston K.L., Bigelow G.E. Drug discrimination assessment of agonist-antagonist opioids in humans. A three-choice saline-hydromorphone-butorphanol procedure J. Pharmacol. Exp. Ther. 271:1994;48-60.
21. Preston K.L., Bigelow G.E., Bickel W.K., Liebson I.A. Three-choice drug discrimination in opioid-dependent humans. Hydromorphone, naloxone and saline J. Pharmacol. Exp. Ther. 243:1987;1002-1009.
22. Preston K.L., Bigelow G.E., Liebson I.A. Discrimination of butorphanol and nalbuphine in opioid-dependent humans. Pharmacol. Biochem. Behav. 37:1990;511-522.
23. Preston K.L., Bigelow G.E., Liebson I.A. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination. J. Pharmacol. Exp. Ther. 261:1992;62-71.
24. Smith, B. J.; Bickel, W. K.: Effects of alprazolam, caffeine and zolpidem in humans trained to discriminate triazolam from placebo: Comparison of a two- and a novel-response procedure. (under review).
25. Stolerman I. Drugs of abuse. Behavioral principles, methods and terms Trends Pharmacol. Sci. 131:1992;170-176.